TCAs versus placebo - National Center for Biotechnology Information

IRWIN1978 (Published Data Only)
Irwin, P. & Fink, M. (1978). Electroencephalogram study of mianserin in depressed patients. British Journal of Clinical Pharmacology, 5 (Suppl. 1), 43S-47S.
ITIL1977 (Published Data Only)
Itil, T. M., Bhattachyaryya, A., Polvan, N., et al. (1977). Fluvoxamine (Du-23,000), a new antidepressant. Quantitative pharmaco-electroencephalography and pilot clinical trials. Progress in Neuro-
Psychopharmacology & Biological Psychiatry, 1, 309-322.
JARVIK1982 (Published Data Only)
Jarvik, L. F., Mintz, J., Steuer, J., et al. (1982). Treating geriatric depression: a 26-week interim analysis. Journal of the American Geriatrics Society, 30, 713-717.
JEFFERSON1983
Jefferson, J. W. & Ayd, J. (1983). Combining lithium and antidepressants. Journal of Clinical Psychopharmacology, 3, 303-307.
JINDAL2003
Jindal, R. D. & Thase, M. E. (2003). Integrating psychotherapy and pharmacotherapy to improve outcomes among patients with mood disorders. Psychiatric Services, 54, 1484-1490.
JOHNSON1993 (Published Data Only)
Johnson, M. R., Lydiard, R. B., Morton, W. A., et al. (1993). Effect of fluvoxamine, imipramine and placebo on catecholamine function in depressed outpatients. Journal of Psychiatric Research, 27,
161-172.
JOHNSON2005
Johnson, G. F. (2005). Mood stabilisers in bipolar disorder. Medicine Today, 6.
JOHNSTONE1980A (Published Data Only)
Johnstone, E. C., Owens, D. G., Frith, C. D., et al. (1980). Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychological Medicine, 10, 321-328.
JUNGKUN2001
Jungkun, G., Kuss, H. J., & Gsell, W. (2001). Long-term effects of tricyclic antidepressants on norepinephrine kinetics in humans. Journal of Neural Transmission, 108, 349-362.
KAHN1986 (Published Data Only)
Kahn, R. J., McNair, D. M., Lipman, R. S., et al. (1986). Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients. Archives of General Psychiatry, 43,
79-85.
KALIN2000
Kalin, N. H. (2000). Management of the depressive component of bipolar disorder. Depression & Anxiety, 4, 190-198.
KANE1982 (Published Data Only)
Kane, J. M., Quitkin, F. M., Rifkin, A., et al. (1982). Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Archives of
General Psychiatry, 39, 1065-1069.
KANE1983 (Published Data Only)
Kane, J. M., Cole, K., Sarantakos, S., et al. (1983). Safety and efficacy of bupropion in elderly patients: preliminary observations. Journal of Clinical Psychiatry, 44, 134-136.
KANTOR1986 (Published Data Only)
Kantor, D., McNevin, S., Leichner, P., et al. (1986). The benefit of lithium carbonate adjunct in refractory depression - fact of fiction? Canadian Journal of Psychiatry - Revue Canadienne de
Psychiatrie, 31, 416-418.
KARP1994
Karp, J. F., Frank, E., Ritenour, A., et al. (1994). Imipramine and sexual dysfunction during the long-term treatment of recurrent depression. Neuropsychopharmacology, 11, 21-27.
KARP2004 (Published Data Only)
Karp, J. F., Buysse, D. J., Houck, P. R., Cherry, C., Kupfer, D. J., & Frank, E. (2004). Relationship of variability in residual symptoms with recurrence of major depressive disorder during
maintenance treatment. American Journal of Psychiatry, 161, 1877-1884.
KATON1993
Katon, W., Sullivan, M., Russo, J., et al. (1993). Depressive symptoms and measures of disability: a prospective study. Journal of Affective Disorders, 27, 245-254.
KATZ1993A (Published Data Only)
Katz, R. J., Lott, M., Landau, P., et al. (1993). A clinical test of noradrenergic involvement in the therapeutic mode of action of an experimental antidepressant. Biological Psychiatry, 33, 261-266.
79